Comprehensive all-in-one platform outperforms five major competitors for injection tracking, nutrition support, side-effect monitoring, and progress visualization NEW YORK, NY - December 8, 2025 - MeAgain is proud to announce its recognition as the #1 GLP-1 tracking app of 2026, following an independent review [ comparing six leading solutions for users on Zepbound, Mounjaro, Wegovy MeAgain Named the #1 Zepbound (Tirzepatide) Tracking App for Weight Management S The MeAgain platform helps users navigate their Zepbound journey with advanced injection tracking, side effect monitoring, and personalized nutrition support NEW YORK, NY - November 10, 2025 - MeAgain is thrilled to announce its recognition as the #1 Zepbound (Tirzepatide) tracking app [ establishing itself as the essential companion for individuals using Zepbound and other Tirzepatide medications to achieve their weight loss goals
"It leaves me up a creek without a paddle," Bonello said
Various fruits offer fibre and antioxidants without causing massive blood sugar spikes
For anyone dealing with a slow metabolism, like those of us with hypothyroidism, this can be a major help
History of Semaglutide and Phentermine Semaglutide was developed by Novo Nordisk as a treatment for type 2 diabetes and marketed as Ozempic in 2017, followed by an oral form called Rybelsus in 2019